88
Participants
Start Date
May 30, 2022
Primary Completion Date
June 26, 2024
Study Completion Date
October 22, 2024
Voxelotor Oral Tablet
Synthetic small molecule supplied as 500 mg tablets, administered Orally
Placebo
Placebo
KEMRI Kondele Children's Hospital within Jaramogi Oginga Odinga Teaching and Referral Hospital., Kisumu
KEMRI-CRDR, KEMRI Clinical Research Annex, Siaya
KEMRI Centre for Clinical Research Butere County Hospital, Butere
Lagos University Teaching Hospital, Lagos
University of Calabar Teaching Hospital, Calabar
Aminu kano Teaching Hospital, Kano
Barau Dikko Teaching Hospital/Kaduna State University, Kaduna
SYNLAB, Gwagwalada
SYNLAB, Abuja
University of Abuja Teaching Hospital, Gwagwalada
Complexo Hospitalar Universitário Professor Edgard Santos- Universidade Federal Da Bahia, Salvador
Universidade Federal Da Bahia Hospital Universitário Professor Edgard Santos, Salvador
Hospital São Rafael, Salvador
Hospital das Clinicas da Universidade Federal de Minas Gerais, Belo Horizonte
Multihemo Servicos Medicos S/A, Recife
Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Cerqueira Cesar - Sao Paulo
Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo
Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto da Universidade de Sao Paulo, Ribeirão Preto
Esho Empresa De Servicos Hospitalares S.A/ Hospital Samaritano Higienopolis, São Paulo
Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo
Gertrude's Children's Hospital, Nairobi
KEMRI-Centre for Respiratory Diseases Research-Nairobi, Nairobi
Strathmore University Medical Centre, Nairobi
Lead Sponsor
Pfizer
INDUSTRY